140 related articles for article (PubMed ID: 30563700)
1. Germline CEBPA mutations in Korean patients with acute myeloid leukemia.
Kim HS; Han E; Jang W; Kim M; Kim Y; Han K; Kim HJ; Cho B
Leuk Res; 2019 Jan; 76():84-86. PubMed ID: 30563700
[No Abstract] [Full Text] [Related]
2. Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset.
Debeljak M; Kitanovski L; Pajič T; Jazbec J
Haematologica; 2013 Jul; 98(7):e73-4. PubMed ID: 23716546
[No Abstract] [Full Text] [Related]
3. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
[TBL] [Abstract][Full Text] [Related]
4. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Xiao H; Shi J; Luo Y; Tan Y; He J; Xie W; Zhang L; Wang Y; Liu L; Wu K; Yu X; Cai Z; Lin M; Ye X; Huang H
Blood; 2011 May; 117(19):5257-60. PubMed ID: 21403128
[TBL] [Abstract][Full Text] [Related]
5. Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation.
Renneville A; Mialou V; Philippe N; Kagialis-Girard S; Biggio V; Zabot MT; Thomas X; Bertrand Y; Preudhomme C
Leukemia; 2009 Apr; 23(4):804-6. PubMed ID: 18946494
[No Abstract] [Full Text] [Related]
6. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia.
Shiba N; Funato M; Ohki K; Park MJ; Mizushima Y; Adachi S; Kobayashi M; Kinoshita A; Sotomatsu M; Arakawa H; Tawa A; Horibe K; Tsukimoto I; Hayashi Y
Br J Haematol; 2014 Jan; 164(1):142-5. PubMed ID: 24033149
[No Abstract] [Full Text] [Related]
7. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
[TBL] [Abstract][Full Text] [Related]
8. Familial CEBPA-mutated acute myeloid leukemia.
Tawana K; Rio-Machin A; Preudhomme C; Fitzgibbon J
Semin Hematol; 2017 Apr; 54(2):87-93. PubMed ID: 28637622
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic features in a patient with germline CEBPA-mutant acute myeloid leukaemia.
Yan B; Ng C; Moshi G; Ban K; Lee PL; Seah E; Chiu L; Koay ES; Liu TC; Ng CH; Chng WJ; Koh LP
J Clin Pathol; 2016 Jul; 69(7):652-4. PubMed ID: 27010436
[No Abstract] [Full Text] [Related]
10. [Investigation and clinical analysis of a family with germline CEBPA mutations in acute myeloid leukemia].
Zhang JP; Lin D; Wang SC; Li Y; Chen YM; Wang Y; Wei H; Mi YC; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1008-1012. PubMed ID: 33445848
[No Abstract] [Full Text] [Related]
11. Hereditary acute myeloid leukemia associated with C-terminal CEBPA germline variants.
Harrigan AM; Trottier AM
Fam Cancer; 2023 Jul; 22(3):331-339. PubMed ID: 36879149
[TBL] [Abstract][Full Text] [Related]
12. A case of acute myeloid leukemia with unusual germline
Mendoza H; Chen PH; Pine AB; Siddon AJ; Bale AE; Gowda L; Killie A; Richards J; Varin-Tremblay C; Kloss R; Podoltsev NA
Leuk Lymphoma; 2021 May; 62(5):1251-1254. PubMed ID: 33345654
[No Abstract] [Full Text] [Related]
13. Getting a handle on hereditary CEBPA mutations.
DiNardo CD
Blood; 2015 Sep; 126(10):1156-8. PubMed ID: 26337351
[No Abstract] [Full Text] [Related]
14. Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.
Yuan J; He R; Alkhateeb HB
Curr Hematol Malig Rep; 2023 Oct; 18(5):121-129. PubMed ID: 37261703
[TBL] [Abstract][Full Text] [Related]
15. [Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].
Wang LM; Xiao HW; Huang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1256-60. PubMed ID: 23114160
[TBL] [Abstract][Full Text] [Related]
16. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML.
Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Mar; 95(4):625-35. PubMed ID: 26692090
[TBL] [Abstract][Full Text] [Related]
17. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
Pabst T; Mueller BU
Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
[TBL] [Abstract][Full Text] [Related]
18. Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL; Hahn CN; Scott HS
Blood; 2020 Jul; 136(1):24-35. PubMed ID: 32430494
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer binding protein-alpha polymorphisms occur more frequently than mutations in acute myeloid leukemia and exist across all cytogenetic risk groups and leukemia subtypes.
Leecharendkeat A; Tocharoentanaphol C; Auewarakul CU
Int J Cancer; 2008 Nov; 123(10):2321-6. PubMed ID: 18729193
[TBL] [Abstract][Full Text] [Related]
20. Clonal Evolution of Acute Myeloid Leukemia with
Li Y; Su L
Turk J Haematol; 2019 May; 36(2):128-130. PubMed ID: 30201598
[No Abstract] [Full Text] [Related]
[Next] [New Search]
